<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39234483</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3376</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Sports medicine and health science</Title><ISOAbbreviation>Sports Med Health Sci</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular abnormalities of long-COVID syndrome: Pathogenic basis and potential strategy for treatment and rehabilitation.</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>231</EndPage><MedlinePgn>221-231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.smhs.2024.03.009</ELocationID><Abstract><AbstractText>Cardiac injury and sustained cardiovascular abnormalities in long-COVID syndrome, i.e. post-acute sequelae of coronavirus disease 2019 (COVID-19) have emerged as a debilitating health burden that has posed challenges for management of pre-existing cardiovascular conditions and other associated chronic comorbidities in the most vulnerable group of patients recovered from acute COVID-19. A clear and evidence-based guideline for treating cardiac issues of long-COVID syndrome is still lacking. In this review, we have summarized the common cardiac symptoms reported in the months after acute COVID-19 illness and further evaluated the possible pathogenic factors underlying the pathophysiology process of long-COVID. The mechanistic understanding of how Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) damages the heart and vasculatures is critical in developing targeted therapy and preventive measures for limiting the viral attacks. Despite the currently available therapeutic interventions, a considerable portion of patients recovered from severe COVID-19 have reported a reduced functional reserve due to deconditioning. Therefore, a rigorous and comprehensive cardiac rehabilitation program with individualized exercise protocols would be instrumental for the patients with long-COVID to regain the physical fitness levels comparable to their pre-illness baseline.</AbstractText><CopyrightInformation>&#xa9; 2024 Chengdu Sport University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kainuo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Virginia Commonwealth University School of Medicine (M.D. Class 2024), Richmond, VA, 23298, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Name</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Virginia Commonwealth University School of Medicine (M.D. Class 2024), Richmond, VA, 23298, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 23298-0204, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Sports Med Health Sci</MedlineTA><NlmUniqueID>101777807</NlmUniqueID><ISSNLinking>2666-3376</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac rehabilitation</Keyword><Keyword MajorTopicYN="N">Exercise intolerance</Keyword><Keyword MajorTopicYN="N">Hypoxia inducible factor 1</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 tropism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39234483</ArticleId><ArticleId IdType="pmc">PMC11369840</ArticleId><ArticleId IdType="doi">10.1016/j.smhs.2024.03.009</ArticleId><ArticleId IdType="pii">S2666-3376(24)00037-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2) doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumoli N., Conte G., Evangelista I., Cei M., Mazzone A., Colombo A. Post-COVID or long-COVID: two different conditions or the same? J&#xa0;Infect Public Health. 2021;14(10):1349&#x2013;1350. doi: 10.1016/j.jiph.2021.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.08.019</ArticleId><ArticleId IdType="pmc">PMC8372476</ArticleId><ArticleId IdType="pubmed">34426096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente-Ros M., Das S., Elias J., Frishman W.H., Aronow W.S. Cardiovascular manifestations of the long COVID syndrome. Cardiol Rev. 2023; April 10 doi: 10.1097/CRD.0000000000000552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000552</ArticleId><ArticleId IdType="pubmed">37071080</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562&#x2013;569. doi: 10.1038/s41564-020-0688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J., Debray M.P., Boussouar S., et al. Residual ground glass opacities three months after COVID-19 pneumonia correlate to alteration of respiratory function: the post COVID M3 study. Respir Med. 2021;184 doi: 10.1016/j.rmed.2021.106435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106435</ArticleId><ArticleId IdType="pmc">PMC8123365</ArticleId><ArticleId IdType="pubmed">34020126</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., et al. Persistent post&#x2013;COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M., Jex N., Thirunavukarasu S., et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case&#x2013;control study. J&#xa0;Cardiovasc Magn Reson. 2022;24(1):50. doi: 10.1186/s12968-022-00887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-022-00887-9</ArticleId><ArticleId IdType="pmc">PMC9464490</ArticleId><ArticleId IdType="pubmed">36089591</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn K.L., Lam G.Y., Walsh J.F., et al. Cardiovascular considerations in the management of people with suspected long COVID. Can J Cardiol. 2023;39(6):741&#x2013;753. doi: 10.1016/j.cjca.2023.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.04.003</ArticleId><ArticleId IdType="pmc">PMC10160565</ArticleId><ArticleId IdType="pubmed">37030518</ArticleId></ArticleIdList></Reference><Reference><Citation>Sova M., Sovova E., Ozana J., et al. Post-COVID syndrome and cardiorespiratory fitness&#x2014;26-month experience of single center. Life. 2023;13(3):684. doi: 10.3390/life13030684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13030684</ArticleId><ArticleId IdType="pmc">PMC10056713</ArticleId><ArticleId IdType="pubmed">36983838</ArticleId></ArticleIdList></Reference><Reference><Citation>Szoltysek-Boldys I., Zielinska-Danch W., Loboda D., et al. Photoplethysmographic measurement of arterial stiffness in Polish patients with Long-COVID-19 Syndrome&#x2014;the results of a cross-sectional study. Diagnostics. 2022;12(12):3189. doi: 10.3390/diagnostics12123189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12123189</ArticleId><ArticleId IdType="pmc">PMC9777579</ArticleId><ArticleId IdType="pubmed">36553195</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;ywaczewska-Jakubowska M., Chudzik M., Babicki M., Kapusta J., Jankowski P. Lifestyle, course of COVID-19, and risk of long-COVID in non-hospitalized patients. Front Med. 2022;9 doi: 10.3389/fmed.2022.1036556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1036556</ArticleId><ArticleId IdType="pmc">PMC9637668</ArticleId><ArticleId IdType="pubmed">36353225</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M., Graziani L., Tilli M., et al. Infection with SARS-CoV-2 variants is associated with different long COVID phenotypes. Viruses. 2022;14(11):2367. doi: 10.3390/v14112367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112367</ArticleId><ArticleId IdType="pmc">PMC9698829</ArticleId><ArticleId IdType="pubmed">36366465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z. More than a key&#x2014;the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury. Sports Med Health Sci. 2023 March;30 doi: 10.1016/j.smhs.2023.03.004. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smhs.2023.03.004</ArticleId><ArticleId IdType="pmc">PMC10062797</ArticleId><ArticleId IdType="pubmed">37361919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano A.C., Nguyen Dinh, Cat A., Rios F.J., Touyz R.M. Angiotensin II and vascular injury. Curr Hypertens Rep. 2014;16(6):431. doi: 10.1007/s11906-014-0431-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-014-0431-2</ArticleId><ArticleId IdType="pubmed">24760441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D., Fitzek A., Br&#xe4;uninger H., et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281. doi: 10.1001/jamacardio.2020.3551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemayel C., Pelliccia A., Thompson P.D. Arrhythmogenic right ventricular cardiomyopathy. J&#xa0;Am Coll Cardiol. 2001;38(7):1773&#x2013;1781. doi: 10.1016/S0735-1097(01)01654-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01654-0</ArticleId><ArticleId IdType="pubmed">11738273</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini P.E., Capecchi P.L., El-Sherif N., Laghi-Pasini F., Boutjdir M. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J&#xa0;Am Heart Assoc. 2018;7(22) doi: 10.1161/JAHA.118.010595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.010595</ArticleId><ArticleId IdType="pmc">PMC6404431</ArticleId><ArticleId IdType="pubmed">30571503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini P.E., Laghi-Pasini F., Boutjdir M., Capecchi P.L. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19(1):63&#x2013;64. doi: 10.1038/s41577-018-0098-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0098-z</ArticleId><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Alcaide P., Asselbergs F.W., et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res. 2023;119(2):336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Edler C., Schr&#xf6;der A.S., Aepfelbacher M., et al. Dying with SARS-CoV-2 infection&#x2014;an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Leg Med. 2020;134(4):1275&#x2013;1284. doi: 10.1007/s00414-020-02317-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00414-020-02317-w</ArticleId><ArticleId IdType="pmc">PMC7271136</ArticleId><ArticleId IdType="pubmed">32500199</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka M.K., Vander Heide R.S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50 doi: 10.1016/j.carpath.2020.107300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Song J., Liu H., Zheng H., Chen C. Positive Epstein&#x2013;Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11(1) doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12 doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M., Bottino N., Tagliabue P., et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J&#xa0;Thromb Haemostasis. 2020;18(7):1738&#x2013;1742. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail M.Y., Diamond A., Kapoor S., Arafah Y., Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020;194:101&#x2013;115. doi: 10.1016/j.thromres.2020.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pmc">PMC7305763</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S., Mendes M.C., Camargo Martins A.P., et al. Endothelial dysfunction and thrombosis in patients with COVID-19&#x2014;brief report. Arterioscler Thromb Vasc Biol. 2020;40(10):2404&#x2013;2407. doi: 10.1161/ATVBAHA.120.314860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314860</ArticleId><ArticleId IdType="pmc">PMC7505138</ArticleId><ArticleId IdType="pubmed">32762443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.J., Liu S.H., Manachevakul S., Lee T.A., Kuo C.T., Bello D. Biomarkers in long COVID-19: a systematic review. Front Med. 2023;10 doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano A.C., Camargo L.L., Mary S., et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13(1) doi: 10.1038/s41598-023-41115-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41115-3</ArticleId><ArticleId IdType="pmc">PMC10462711</ArticleId><ArticleId IdType="pubmed">37640791</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosimi L.A., Kelly C., Esposito S., et al. Duration of symptoms and association with positive home rapid antigen test results after infection with SARS-CoV-2. JAMA Netw Open. 2022;5(8) doi: 10.1001/jamanetworkopen.2022.25331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25331</ArticleId><ArticleId IdType="pmc">PMC9350709</ArticleId><ArticleId IdType="pubmed">35921111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Br&#xfc;ningk S.C., Hoch T., et al. Persistent complement dysregulation with signs of thromboinflammation in active long COVID. Science. 2024;383(6680):eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossi F., Rizzi L., Bulla R., et al. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood. 2009;113(15):3640&#x2013;3648. doi: 10.1182/blood-2008-03-146472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-03-146472</ArticleId><ArticleId IdType="pubmed">19179470</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang C.Y., Wang S.I., Wei J.C.C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. eClinicalMedicine. 2022;53 doi: 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101619</ArticleId><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J&#xa0;Thromb Haemostasis. 2020;18(4):844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>de Menezes D.C., de Lima P.D.L., de Lima I.C., et al. Metabolic profile of patients with long COVID: a cross-sectional study. Nutrients. 2023;15(5):1197. doi: 10.3390/nu15051197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051197</ArticleId><ArticleId IdType="pmc">PMC10005061</ArticleId><ArticleId IdType="pubmed">36904195</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., tenOever B.R. Cardiometabolic syndrome &#x2014; an emergent feature of Long COVID? Nat Rev Immunol. 2022;22(7):399&#x2013;400. doi: 10.1038/s41577-022-00739-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00739-8</ArticleId><ArticleId IdType="pmc">PMC9127811</ArticleId><ArticleId IdType="pubmed">35610313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Uhl S., Zhang T., et al. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metabol. 2021;33(8):1577&#x2013;1591.e7. doi: 10.1016/j.cmet.2021.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8133495</ArticleId><ArticleId IdType="pubmed">34081913</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M., Rajan M., G&#xf3;mez-Banoy N., et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metabol. 2021;33(11):2174&#x2013;2188.e5. doi: 10.1016/j.cmet.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanai H., Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):1190. doi: 10.3390/ijms20051190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20051190</ArticleId><ArticleId IdType="pmc">PMC6429491</ArticleId><ArticleId IdType="pubmed">30857216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Bayry J. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol. 2023;19(7):399&#x2013;400. doi: 10.1038/s41584-023-00964-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O., Varionchik N., Zaidenov V., Savina P., Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol. 2021;51(4):893&#x2013;902. doi: 10.1002/eji.202048930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048930</ArticleId><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A., Ruiz-Ruig&#xf3;mez M., Laguna-Goya R., et al. A&#xa0;short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. 2021;9(11):1540. doi: 10.3390/biomedicines9111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Radovanovic D., Rizzi M., Pini S., Saad M., Chiumello D.A., Santus P. Helmet CPAP to treat acute hypoxemic respiratory failure in patients with COVID-19: a management strategy proposal. J&#xa0;Clin Med. 2020;9(4):1191. doi: 10.3390/jcm9041191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9041191</ArticleId><ArticleId IdType="pmc">PMC7230457</ArticleId><ArticleId IdType="pubmed">32331217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani M., Dokaneheifard S., Mansouri K. Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J&#xa0;Inflamm. 2020;17(1):33. doi: 10.1186/s12950-020-00263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-020-00263-3</ArticleId><ArticleId IdType="pmc">PMC7594974</ArticleId><ArticleId IdType="pubmed">33139969</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilaki N., Frakolaki E. Virus&#x2013;host interactions under hypoxia. Microb Infect. 2017;19(3):193&#x2013;203. doi: 10.1016/j.micinf.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2016.10.004</ArticleId><ArticleId IdType="pubmed">27771294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Su H., Ma X., et al. miRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L547&#x2013;L557. doi: 10.1152/ajplung.00387.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00387.2018</ArticleId><ArticleId IdType="pubmed">30628484</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez E.V., Reece K.M., Ley A.M., et al. Dual targeting of the androgen receptor and hypoxia-inducible factor 1&#x3b1; pathways synergistically inhibits castration-resistant prostate cancer cells. Mol Pharmacol. 2015;87(6):1006&#x2013;1012. doi: 10.1124/mol.114.097477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.114.097477</ArticleId><ArticleId IdType="pmc">PMC4429716</ArticleId><ArticleId IdType="pubmed">25829060</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi K., Oda T., Takabuchi S., et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species&#x2013;dependent manner. Antioxidants Redox Signal. 2008;10(5):983&#x2013;996. doi: 10.1089/ars.2007.1825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1825</ArticleId><ArticleId IdType="pubmed">18199003</ArticleId></ArticleIdList></Reference><Reference><Citation>Palsson-McDermott E.M., O'Neill L.A.J. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35(11):965&#x2013;973. doi: 10.1002/bies.201300084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201300084</ArticleId><ArticleId IdType="pubmed">24115022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasundaram S. Adenosine A2A receptor signaling in the immunopathogenesis of experimental autoimmune encephalomyelitis. Front Immunol. 2018;9:402. doi: 10.3389/fimmu.2018.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00402</ArticleId><ArticleId IdType="pmc">PMC5845642</ArticleId><ArticleId IdType="pubmed">29559972</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos S.A., de Andrade J&#xfa;nior D.R. HIF-1alpha and infectious diseases: a new frontier for the development of new therapies. Rev Inst Med Trop Sao Paulo. 2017;59:e92. doi: 10.1590/s1678-9946201759092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1678-9946201759092</ArticleId><ArticleId IdType="pmc">PMC5738998</ArticleId><ArticleId IdType="pubmed">29267600</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., He L., Zhang E., et al. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1&#x3b1; and VEGF expression in non-small cell lung cancer cells. Cancer Lett. 2011;311(2):160&#x2013;170. doi: 10.1016/j.canlet.2011.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2011.07.012</ArticleId><ArticleId IdType="pubmed">21868151</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes A.S., Botelho S.M., Santos L.R., Rezende A.L. Acute COVID-19 syndrome predicts severe long COVID-19: an observational study. Cureus. 2022;14(10) doi: 10.7759/cureus.29826.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29826</ArticleId><ArticleId IdType="pmc">PMC9527039</ArticleId><ArticleId IdType="pubmed">36204261</ArticleId></ArticleIdList></Reference><Reference><Citation>Terzic C.M., Medina-Inojosa B.J. Cardiovascular complications of coronavirus disease-2019. Phys Med Rehabil Clin. 2023;34(3):551&#x2013;561. doi: 10.1016/j.pmr.2023.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2023.03.003</ArticleId><ArticleId IdType="pmc">PMC10063539</ArticleId><ArticleId IdType="pubmed">37419531</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman T.J., Bhave N.M., Allen L.A., et al. ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play. J&#xa0;Am Coll Cardiol. 2022;79(17):1717&#x2013;1756. doi: 10.1016/j.jacc.2022.02.003. 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieksiene K., Zaveckiene J., Malakauskas K., Vaguliene N., Zemaitis M., Miliauskas S. Post COVID-19 organizing pneumonia: the right time to interfere. Medicina. 2021;57(3):283. doi: 10.3390/medicina57030283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030283</ArticleId><ArticleId IdType="pmc">PMC8003092</ArticleId><ArticleId IdType="pubmed">33803690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Rosas I.O., Singer M. Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity. Intensive Care Med. 2022;48(12):1803&#x2013;1806. doi: 10.1007/s00134-022-06877-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06877-w</ArticleId><ArticleId IdType="pmc">PMC9453725</ArticleId><ArticleId IdType="pubmed">36074167</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosano G.M.C., Vitale C., Adamo M., Metra M. Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice. J&#xa0;Cardiovasc Med. 2022;23(3):149&#x2013;156. doi: 10.2459/JCM.0000000000001221.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001221</ArticleId><ArticleId IdType="pmc">PMC10484190</ArticleId><ArticleId IdType="pubmed">34937849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kovacs R., Harrington B. Joint HFSA/ACC/AHA Statement addresses concerns Re: using RAAS antagonists in COVID-19. J&#xa0;Card Fail. 2020;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7234783</ArticleId><ArticleId IdType="pubmed">32439095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes R.D., Macedo A.V.S., de Barros E Silva P.G.M., et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19. JAMA. 2021;325(3):254. doi: 10.1001/jama.2020.25864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.25864</ArticleId><ArticleId IdType="pmc">PMC7816106</ArticleId><ArticleId IdType="pubmed">33464336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey J.R., Caro-Cod&#xf3;n J., Rosillo S.O., et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020;22(12):2205&#x2013;2215. doi: 10.1002/ejhf.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1990</ArticleId><ArticleId IdType="pmc">PMC7461427</ArticleId><ArticleId IdType="pubmed">32833283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Battisti V., Costola G., Roncon L., Bilato C. Increased risk of acute myocardial infarction after COVID-19 recovery: a systematic review and meta-analysis. Int J Cardiol. 2023;372:138&#x2013;143. doi: 10.1016/j.ijcard.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.12.032</ArticleId><ArticleId IdType="pmc">PMC9755219</ArticleId><ArticleId IdType="pubmed">36535564</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2) doi: 10.1183/13993003.00870-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00870-2021</ArticleId><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaffney F.A., Nixon J.V., Karlsson E.S., Campbell W., Dowdey A.B.C., Blomqvist C.G. Cardiovascular deconditioning produced by 20 hours of bedrest with head-down tilt (&#x2212;5&#xb0;) in middle-aged healthy men. Am J Cardiol. 1985;56(10):634&#x2013;638. doi: 10.1016/0002-9149(85)91025-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(85)91025-2</ArticleId><ArticleId IdType="pubmed">4050700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudofker E.W., Parker H., Cornwell W.K. An exercise prescription as a novel management strategy for treatment of long COVID. JACC Case Rep. 2022;4(20):1344&#x2013;1347. doi: 10.1016/j.jaccas.2022.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2022.06.026</ArticleId><ArticleId IdType="pmc">PMC9580598</ArticleId><ArticleId IdType="pubmed">36278147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia A., Maron B.J., Spataro A., Proschan M.A., Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N&#xa0;Engl J Med. 1991;324(5):295&#x2013;301. doi: 10.1056/NEJM199101313240504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199101313240504</ArticleId><ArticleId IdType="pubmed">1824720</ArticleId></ArticleIdList></Reference><Reference><Citation>Serviente C., Decker S.T., Layec G. From heart to muscle: pathophysiological mechanisms underlying long-term physical sequelae from SARS-CoV-2 infection. J&#xa0;Appl Physiol. 2022;132(3):581&#x2013;592. doi: 10.1152/japplphysiol.00734.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00734.2021</ArticleId><ArticleId IdType="pmc">PMC8873035</ArticleId><ArticleId IdType="pubmed">35019775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T., Kurano M., Fukumura K., et al. Cardiac rehabilitation increases exercise capacity with a reduction of oxidative stress. Korean Circ J. 2013;43(7):481. doi: 10.4070/kcj.2013.43.7.481.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2013.43.7.481</ArticleId><ArticleId IdType="pmc">PMC3744736</ArticleId><ArticleId IdType="pubmed">23964295</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson J.J., Crooks C., Naja M., et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol. 2020;2(10):e594&#x2013;e602. doi: 10.1016/S2665-9913(20)30275-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30275-7</ArticleId><ArticleId IdType="pmc">PMC7442426</ArticleId><ArticleId IdType="pubmed">32864628</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavigli L., Fusi C., Focardi M., et al. Post-acute sequelae of COVID-19: the potential role of exercise therapy in treating patients and athletes returning to play. J&#xa0;Clin Med. 2022;12(1):288. doi: 10.3390/jcm12010288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010288</ArticleId><ArticleId IdType="pmc">PMC9821682</ArticleId><ArticleId IdType="pubmed">36615087</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ascenzi F., Castelletti S., Adami P.E., et al. Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: a clinical consensus statement of the task force for childhood health of the European association of preventive Cardiology. Eur J Prev Cardiol. 2022;29(16):2120&#x2013;2124. doi: 10.1093/eurjpc/zwac180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwac180</ArticleId><ArticleId IdType="pmc">PMC9494331</ArticleId><ArticleId IdType="pubmed">36059208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A., Dannerbeck L., Lange T.J., et al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidiscip Respir Med. 2021;16(1):732. doi: 10.4081/mrm.2021.732.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2021.732</ArticleId><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Chen R., Geng Q., et al. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J. 2021;57(1) doi: 10.1183/13993003.04265-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04265-2020</ArticleId><ArticleId IdType="pmc">PMC7758779</ArticleId><ArticleId IdType="pubmed">33361097</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19. Chest. 2022;161(1):54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Author Correction: long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(6):408. doi: 10.1038/s41579-023-00896-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00896-0</ArticleId><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M., Myatra S.N., Munblit D., Elhazmi A., Ranzani O.T., Herridge M.S. Recovery after prolonged ICU treatment in patients with COVID-19. Lancet Respir Med. 2021;9(8):812&#x2013;814. doi: 10.1016/S2213-2600(21)00318-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00318-0</ArticleId><ArticleId IdType="pmc">PMC8280055</ArticleId><ArticleId IdType="pubmed">34273267</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier F., B&#xe9;rub&#xe9; B., Malo J., et al. Cardiopulmonary rehabilitation in long-COVID-19 patients with persistent breathlessness and fatigue: the COVID-Rehab Study. Int J Environ Res Publ Health. 2022;19(7):4133. doi: 10.3390/ijerph19074133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19074133</ArticleId><ArticleId IdType="pmc">PMC8998214</ArticleId><ArticleId IdType="pubmed">35409815</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Garc&#xed;a J.C., Reinoso-Cobo A., Piqueras-Sola B., et al. Long COVID and physical therapy: a systematic review. Diseases. 2023;11(4):163. doi: 10.3390/diseases11040163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases11040163</ArticleId><ArticleId IdType="pmc">PMC10660729</ArticleId><ArticleId IdType="pubmed">37987274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouliopoulou D.V., Macdermid J.C., Saunders E., et al. Rehabilitation interventions for physical capacity and quality of life in adults with post&#x2013;COVID-19 condition. JAMA Netw Open. 2023;6(9) doi: 10.1001/jamanetworkopen.2023.33838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.33838</ArticleId><ArticleId IdType="pmc">PMC10509723</ArticleId><ArticleId IdType="pubmed">37725376</ArticleId></ArticleIdList></Reference><Reference><Citation>del Corral T., Fabero-Garrido R., Plaza-Manzano G., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., L&#xf3;pez-de-Uralde-Villanueva I. Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19: randomized controlled trial. Ann Phys Rehabil Med. 2023;66(1) doi: 10.1016/j.rehab.2022.101709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2022.101709</ArticleId><ArticleId IdType="pmc">PMC9708524</ArticleId><ArticleId IdType="pubmed">36191860</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota S., Miyamae T., Kuroiwa Y., Nishioka K. Novel Coronavirus Disease 2019 (COVID-19) and cytokine storms for more effective treatments from an inflammatory pathophysiology. J&#xa0;Clin Med. 2021;10(4):801. doi: 10.3390/jcm10040801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040801</ArticleId><ArticleId IdType="pmc">PMC7922214</ArticleId><ArticleId IdType="pubmed">33671159</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637&#x2013;1645. doi: 10.1016/S0140-6736(21)00676-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00676-0</ArticleId><ArticleId IdType="pmc">PMC8084355</ArticleId><ArticleId IdType="pubmed">33933206</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoud G.N., Li W. HIF-1&#x3b1; pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015;5(5):378&#x2013;389. doi: 10.1016/j.apsb.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2015.05.007</ArticleId><ArticleId IdType="pmc">PMC4629436</ArticleId><ArticleId IdType="pubmed">26579469</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekin D., Dursun A.D., Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin. 2010;31(9):1085&#x2013;1094. doi: 10.1038/aps.2010.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2010.132</ArticleId><ArticleId IdType="pmc">PMC4002308</ArticleId><ArticleId IdType="pubmed">20711226</ArticleId></ArticleIdList></Reference><Reference><Citation>Serebrovska Z.O., Chong E.Y., Serebrovska T.V., Tumanovska L.V., Xi L. Hypoxia, HIF-1&#x3b1;, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020;41(12):1539&#x2013;1546. doi: 10.1038/s41401-020-00554-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-00554-8</ArticleId><ArticleId IdType="pmc">PMC7588589</ArticleId><ArticleId IdType="pubmed">33110240</ArticleId></ArticleIdList></Reference><Reference><Citation>Serebrovskaya T.V., Xi L. Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: practical analysis on methods and equipment. Exp Biol Med. 2016;241(15):1708&#x2013;1723. doi: 10.1177/1535370216657614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216657614</ArticleId><ArticleId IdType="pmc">PMC4999622</ArticleId><ArticleId IdType="pubmed">27407098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Kang H., Liu X., Tong Z. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J&#xa0;Med Virol. 2020;92(6):538&#x2013;539. doi: 10.1002/jmv.25721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25721</ArticleId><ArticleId IdType="pmc">PMC7233289</ArticleId><ArticleId IdType="pubmed">32096564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostimskaya I. CRISPR&#x2013;Cas9: a history of its discovery and ethical considerations of its use in genome editing. Biochemistry. 2022;87(8):777&#x2013;788. doi: 10.1134/S0006297922080090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297922080090</ArticleId><ArticleId IdType="pmc">PMC9377665</ArticleId><ArticleId IdType="pubmed">36171658</ArticleId></ArticleIdList></Reference><Reference><Citation>Freije C.A., Myhrvold C., Boehm C.K., et al. Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell. 2019;76(5):826&#x2013;837.e11. doi: 10.1016/j.molcel.2019.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.013</ArticleId><ArticleId IdType="pmc">PMC7422627</ArticleId><ArticleId IdType="pubmed">31607545</ArticleId></ArticleIdList></Reference><Reference><Citation>Berber B., Aydin C., Kocabas F., et al. Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics. Gene Ther. 2021;28(6):290&#x2013;305. doi: 10.1038/s41434-020-00209-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41434-020-00209-7</ArticleId><ArticleId IdType="pmc">PMC7734466</ArticleId><ArticleId IdType="pubmed">33318646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Rossi J.J. RNAi mechanisms and applications. Biotechniques. 2008;44(5):613&#x2013;616. doi: 10.2144/000112792.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000112792</ArticleId><ArticleId IdType="pmc">PMC2727154</ArticleId><ArticleId IdType="pubmed">18474035</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmastroni E., Galimberti F., Tragni E., Catapano A.L., Casula M. Impact of COVID-19 pandemic on adherence to chronic therapies: a systematic review. Int J Environ Res Publ Health. 2023;20(5):3825. doi: 10.3390/ijerph20053825.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20053825</ArticleId><ArticleId IdType="pmc">PMC10001666</ArticleId><ArticleId IdType="pubmed">36900831</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche C., Fisher A., Fancourt D., Burton A. Exploring barriers and facilitators to physical activity during the COVID-19 pandemic: a qualitative study. Int J Environ Res Publ Health. 2022;19(15):9169. doi: 10.3390/ijerph19159169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159169</ArticleId><ArticleId IdType="pmc">PMC9367830</ArticleId><ArticleId IdType="pubmed">35954538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouabida K., Lebouch&#xe9; B., Pomey M.P. Telehealth and COVID-19 pandemic: an overview of the telehealth use, advantages, challenges, and opportunities during COVID-19 pandemic. Healthcare. 2022;10(11):2293. doi: 10.3390/healthcare10112293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10112293</ArticleId><ArticleId IdType="pmc">PMC9690761</ArticleId><ArticleId IdType="pubmed">36421617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal B., Porto N., Kiss D.E., Cho S.H., Head L.S. Health insurance coverage during the COVID-19 pandemic: the role of Medicaid expansion. J&#xa0;Consum Aff. 2023;57(1):296&#x2013;319. doi: 10.1111/joca.12500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joca.12500</ArticleId><ArticleId IdType="pmc">PMC9877596</ArticleId><ArticleId IdType="pubmed">36718253</ArticleId></ArticleIdList></Reference><Reference><Citation>Resurrecci&#xf3;n D.M., Motrico E., Rubio-Valera M., Mora-Pardo J.A., Moreno-Peral P. Reasons for dropout from cardiac rehabilitation programs in women: a qualitative study. PLoS One. 2018;13(7) doi: 10.1371/journal.pone.0200636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200636</ArticleId><ArticleId IdType="pmc">PMC6047805</ArticleId><ArticleId IdType="pubmed">30011341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H.J., Lin C.W., Hsiao M.Y., Wang T.G., Liang H.W. Long COVID and rehabilitation. J&#xa0;Formos Med Assoc. 2024;123:S61&#x2013;S69. doi: 10.1016/j.jfma.2023.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10101546</ArticleId><ArticleId IdType="pubmed">37061399</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>